Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
2013 · Nature Communications · 462 citations
https://doi.org/10.1038/ncomms2886
Q
Qilong Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
104
Papers
2.3K
Citations
25
h-index
48
i10-index
Qilong Wang is an academic researcher. The author has contributed to research in topics: MicroRNA in disease regulation & Nanoparticle-Based Drug Delivery & RNA Interference and Gene Delivery. The author has an h-index of 25, co-authored 89 publications.
ORCID: 0000-0002-0491-1915Papers by this author
worksBlood exosomes regulate the tissue distribution of grapefruit-derived nanovector via CD36 and IGFR1 pathways
2018 · Theranostics · 67 citations
https://doi.org/10.7150/thno.27608
Aptamer-conjugated and doxorubicin-loaded grapefruit-derived nanovectors for targeted therapy against HER2<sup>+</sup> breast cancer
2019 · Journal of drug targeting · 45 citations
https://doi.org/10.1080/1061186x.2019.1624970
A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage differentiation
2016 · Cell Discovery · 25 citations
https://doi.org/10.1038/celldisc.2015.43
<scp>LRFN2</scp> binding to <scp>NMDAR</scp> inhibits the progress of <scp>ESCC</scp> via regulating the Wnt/<scp>β‐Catenin</scp> and <scp>NF‐κB</scp> signaling pathway
2022 · Cancer Science · 10 citations
https://doi.org/10.1111/cas.15510
Paclitaxel/Luteolin Coloaded Dual‐Functional Liposomes for Esophageal Cancer Therapy
2025 · Advanced Science · 9 citations
https://doi.org/10.1002/advs.202411930
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat